Literature DB >> 385504

Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge.

L M Pope, G T Cole, M N Guentzel, L J Berry.   

Abstract

Systemic and gastrointestinal infection can be established in infant mice after intragastric challenge with Candida albicans. Differences in virulence of the six strains tested were noted. As early as 3 h after infection, some but not all livers, spleens, and kidneys contained C. albicans, but the peak number of colony-forming units in these organs was seen at 6 h. The early colonization of the organs could not be attributed to aspiration of the inoculum since about 90% of lungs and livers tested yielded no colony-forming units at 10 to 15 min postinfection. In animals with systemic infections, lungs, livers, kidneys, and spleens showed similar numbers of colony-forming units within the organs during the first 6 h postinfection- and then the number declined progressively up to 72 h. The gastrointestinal tract was colonized throughout a 20-day period of study. Counts made at intervals beyond day 1 yielded between 10(5) and 10(6) colony-forming units in the stomach, ileum, and cecum. Preparatory techniques for scanning electron microscopy preserved the yeast, intestinal mucus layer, and epithelial surface and made it possible to visualize the association between the pathogen and host tissues within the digestive tract.

Entities:  

Mesh:

Year:  1979        PMID: 385504      PMCID: PMC414501          DOI: 10.1128/iai.25.2.702-707.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Pneumocystis and fungal infection in patients with malignancies.

Authors:  J S Remington; S E Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

2.  The fate of bacteria in the small intestine.

Authors:  J M DIXON
Journal:  J Pathol Bacteriol       Date:  1960-01

3.  Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.

Authors:  V Baselski; R Briggs; C Parker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Fungaemia and funguria after oral administration of Candida albicans.

Authors:  W Krause; H Matheis; K Wulf
Journal:  Lancet       Date:  1969-03-22       Impact factor: 79.321

5.  Enteric pathogen--normal flora interactions.

Authors:  D J Hentges
Journal:  Am J Clin Nutr       Date:  1970-11       Impact factor: 7.045

6.  Use of fluorescent antibody in studies of immunity to cholera in infant mice.

Authors:  M N Guentzel; L H Field; E R Eubanks; L J Berry
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

7.  Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine.

Authors:  A DeMaria; H Buckley; F von Lichtenberg
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

8.  Preservation of gastrointestinal bacteria and their microenvironmental associations in rats by freezing.

Authors:  C P Davis
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

9.  Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells.

Authors:  V S Baselski; C D Parker
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Systemic candidiasis produced by oral Candida administration in mice.

Authors:  T Umenai
Journal:  Tohoku J Exp Med       Date:  1978-10       Impact factor: 1.848

View more
  39 in total

1.  Intestinal lesions associated with disseminated candidiasis in an experimental animal model.

Authors:  K A Andrutis; P J Riggle; C A Kumamoto; S Tzipori
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

3.  A murine model for disseminated candidiasis in neonates.

Authors:  Nancy Y Tsai; Sonia S Laforce-Nesbitt; Richard Tucker; Joseph M Bliss
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

4.  Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; E van Strijen; B R Sekh; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Factors governing adherence of Candida species to plastic surfaces.

Authors:  S A Klotz; D J Drutz; J E Zajic
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

8.  Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.

Authors:  David Kadosh; Laura K Najvar; Rosie Bocanegra; Marcos Olivo; William R Kirkpatrick; Nathan P Wiederhold; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.

Authors:  C Herrera; M N Guentzel
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.

Authors:  E Balish; M J Balish; C A Salkowski; K W Lee; K F Bartizal
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.